Skip to content

A Clinical Study on Abhishyanda(Allergic Conjunctivitis) and its management with Shigruadi eye drops and Haridrakhanda

A Clinical Study on Abhishyanda(Allergic Conjunctivitis) and its management with Shigruadi eye drops and Haridrakhanda

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/02/011943
Enrollment
45
Registered
2018-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having Allergic Conjuctivitis

Interventions

Intervention1: Shigruadi eye drops: Group â?? A: Patients will be administered with Shigruadi eye drops Dose: 1 drop 4 â?? 6 times daily FOR 6 WEEKS Intervention2: Haridra khan

Sponsors

IPGT AND RA GAU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age of the patients in between 10 â?? 35 years. 2.The patients having the signs and symptoms of Abhishyanda â?? Allergic conjunctivitis.

Exclusion criteria

Exclusion criteria: 1.Patients having complications like corneal involvement like marginal corneal ulcer, dacryocyctites, trachoma, kerato conjunctivitis etc. 2.Patients below 10 years and above 35 years 3.Infective conjunctivitis 4.All types of Conjunctivitis (Acute & Chronic) which are non allergic in nature are excluded from the Study.

Design outcomes

Primary

MeasureTime frame
1. A critical study on etio-pathogenesis of Abhishyanda - Allergic Conjunctivitis from Ayurvedic and modern point of view. 2. To evaluate the combined efficacy of shigruadi eye drops topically and Haridrakhanda orally in the management of Allergic Conjunctivitis. Timepoint: 1. Conceptual Study-Completed 2. Clinical Study-Till March-2014

Secondary

MeasureTime frame
1. Standardization of procedure (SOPs) in respect to shigruadi eye drops.Timepoint: 1. Conceptual Study-Completed 2. Clinical Study-Till March-2014

Countries

India

Contacts

Public ContactDr Mantu Das

IPGT AND RA, G.A.U. JAMNAGAR

bhatrajma2008@gmail.com9428400759

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026